FASEB J. Thermo Fisher
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.09-141044.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.09-141044v1
24/2/587    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varani, K.
Right arrow Articles by Borea, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varani, K.
Right arrow Articles by Borea, P. A.
(The FASEB Journal. 2010;24:587-598.)
© 2010 FASEB

A2A adenosine receptor overexpression and functionality, as well as TNF-{alpha} levels, correlate with motor symptoms in Parkinson’s disease

Katia Varani*, Fabrizio Vincenzi*, Alice Tosi*, Stefania Gessi*, Ilaria Casetta{ddagger}, Gino Granieri{dagger}, Patrik Fazio{ddagger}, Edward Leung§, Stephen MacLennan§, Enrico Granieri{ddagger} and Pier Andrea Borea*,1

* Department of Clinical and Experimental Medicine, Pharmacology Section, and

{dagger} Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy;

{ddagger} Neurological Clinic, University Hospital of Ferrara, Ferrara, Italy; and

§ King Pharmaceuticals Inc, Research and Development, Cary, North Carolina, USA

1 Correspondence: Department of Clinical and Experimental Medicine, Pharmacology Unit, University of Ferrara, via Fossato di Mortara 17-19 44100 Ferrara, Italy. E-mail: bpa{at}unife.it

The antagonistic interaction between adenosine and dopamine receptors could have important pathophysiological and therapeutic implications in Parkinson’s disease (PD). The primary aim of this study was to investigate the expression, affinity, and density of A1, A2A, A2B, and A3 adenosine receptors (ARs) and D2 dopamine receptors (D2Rs) in PD. An increase in A2AAR density in putamen was found. The presence and functionality of ARs in human lymphocyte and neutrophil membranes from patients with PD revealed a specific A2AAR alteration compared with healthy subjects. A statistically significant linear correlation among the A2AAR density, functionality, or tumor necrosis factor-{alpha} (TNF-{alpha}) levels and Unified Parkinson’s Disease Rating Scale (UPDRS) motor score was reported. Adenosine concentration and TNF-{alpha} levels were increased in plasma of patients with PD. In rat adrenal pheochromocytoma (PC12) cells, a widely useful model, adenosine antagonists decreased dopamine uptake, and an opposite effect was mediated by A2A agonists. This is the first report showing the presence of an A2AAR alteration in putamen in PD that mirrors a similar up-regulation in human peripheral blood cells. Moreover, the correlation found between A2AAR density or A2A agonist potency and UPDRS motor score highlights the central role of A2AARs in the pharmacological treatment of PD.—Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., Fazio, P., Leung, E., MacLennan, S., Granieri, E., Borea, P. A. A2A adenosine receptor overexpression and functionality, as well as TNF-{alpha} levels, correlate with motor symptoms in Parkinson’s disease.


Key Words: D2 dopamine receptors • human putamen • human lymphocytes and neutrophils




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. T. Parish, S. Kim, R. K. Sekhon, J. E. Wu, Y. Kawakatsu, and R. B. Effros
Adenosine Deaminase Modulation of Telomerase Activity and Replicative Senescence in Human CD8 T Lymphocytes
J. Immunol., March 15, 2010; 184(6): 2847 - 2854.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2010 by The Federation of American Societies for Experimental Biology.